Home
Categories
EXPLORE
History
Comedy
Religion & Spirituality
Society & Culture
Music
True Crime
Education
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
HN
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/43/bc/67/43bc6734-2f26-36da-f4fa-c935cf749ee0/mza_4535681404373065078.jpg/600x600bb.jpg
The Readout Loud
STAT
380 episodes
5 days ago
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Show more...
Business
RSS
All content for The Readout Loud is the property of STAT and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Show more...
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/43/bc/67/43bc6734-2f26-36da-f4fa-c935cf749ee0/mza_4535681404373065078.jpg/600x600bb.jpg
375: Startups push the FDA and biotech booms in North Carolina
The Readout Loud
29 minutes
1 week ago
375: Startups push the FDA and biotech booms in North Carolina
Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? And who wore a tuxedo to the STAT Summit? We discuss all that and more in the latest episode of "The Readout LOUD."Elaine is out this week, so Adam and Allison dive into the latest news in the life science industry together, including the two companies pushing the Food and Drug Administration, the first recipients of the Commissioner’s National Priority Review voucher, and why Flagship Pioneering founder Nobuar Afeyan thinks that mRNA vaccines are the canary in the coal mine that is the drug industry. Adam also asks Allison about her trip to North Carolina to check out the local biomanufacturing boom.
The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.